Published by Josh White on 28th May 2019
(Sharecast News) - Gene and cell therapy company Oxford Biomedica announced on Tuesday that Novo Holdings has agreed to invest up to £53.5m in the group, in return for new ordinary shares representing up to 10.1% of the outstanding shares after the capital increase.
URL: http://www.digitallook.com/dl/news/story/29090235/...